Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

As the second antibody-drug conjugate launched by Daiichi Sankyo and AstraZeneca, Datroway has a tough act to follow, coming on the heels of the companies’ emerging ADC cancer powerhouse Enhertu.

Daiichi Sankyo reported full-year revenue of JPY 1,886 billion and core operating profit of JPY 332 billion. It issued full-year guidance of JPY 2 trillion revenue and JPY 350 billion core ...

Dan Switzer, head of the US oncology business division at Daiichi Sankyo, spoke with Pharmaceutical Executive about the company’s history with this festival and it connects to its current values.

Since the earthquake struck, the ICRC, in partnership with the Myanmar Red Cross Society and local civil society organizations, has been working constantly to provide much needed support and ...

This comes amidst good rabi crop arrivals and expectations of higher imports from Myanmar, which has harvested a record crop this year. Also, with summer crop set to hit the markets in state such ...

The ground in Myanmar was split and dragged in different directions during the massive 7.7 magnitude earthquake that hit the Southeast Asian nation on March 28. The quake tore a rupture through ...

BANGKOK/KUALA LUMPUR -- Senior Gen. Min Aung Hlaing, the leader of the military regime of civil war-ravaged Myanmar, has given no indication whether he will extend the ceasefire he declared in ...

YANGON, Myanmar — Myanmar's military junta let a truce declared to spur aid efforts after last month's earthquake expire on Thursday, a ceasefire that monitors say it consistently violated with air ...

(Bangkok) – The Myanmar military junta’s years of unlawful attacks on healthcare facilities and health workers have severely hindered the emergency response to the devastating earthquake on ...